Variables | GIR | p | ||
---|---|---|---|---|
Group I n (%) n = 21 | Gorup II n (%) n = 67 | Group III n (%) n = 9 | ||
Gender | ||||
 Male | 14 (66.7) | 33 (49.3) | 3 (33.3) | 0.196 |
 Female | 7 (33.3) | 34 (50.7) | 6 (66.7) |  |
Gestational age | ||||
  < 30 weeks | 0 (0.0) | 12 (17.9) | 2 (22.2) | 0.179 |
 30 - < 34 weeks | 6 (28.6) | 24 (35.8) | 3 (33.3) |  |
 34 - < 37 weeks | 15 (71.4) | 31 (46.3) | 4 (44.5) |  |
Birth weight | ||||
  < 1000 g | 1 (4.7) | 12 (17.9) | 2 (22.2) | 0.151 |
 1000 - < 1500 g | 6 (28.7) | 21 (31.3) | 2 (22.2) |  |
 1500 - < 2000 g | 13 (61.9) | 20 (29.9) | 4 (44.5) |  |
 2000 - < 2500 g | 1 (4.7) | 14 (20.9) | 1 (11.1) |  |
Outcome | ||||
 Mortality | 1 (4.7) | 13 (19.4) | 3 (33.3) | 0.130 |
 Survive | 20 (95.3) | 54 (80.6) | 6 (66.7) |  |
Neonatal morbidity | ||||
 RDS | 10 (47.6) | 37 (55.2) | 4 (44.5) | 0.728 |
 NEC | 3 (14.3) | 4 (5.9) | 2 (22.2) | 0.193 |
 Sepsis | 1 (4.7) | 22 (32.8) | 4 (44.5) | 0.022* |
 ROP | 3 (14.3) | 7 (10.4) | 0 (0.0) | 0.498 |
 Pulmonary hypertension | 3 (14.3) | 5 (7.5) | 1 (11.1) | 0.630 |
 Hypoglycemia | 9 (42.9) | 11 (16.4) | 1 (11.1) | 0.027* |
 Hyperglycemia | 2 (9.5) | 9 (13.4) | 2 (22.2) | 0.645 |